期刊文献+

原发性醛固酮增多症代谢紊乱及心血管事件研究进展 被引量:2

Metabolic disturbance and cardiovascular events in primary aldosteronism:recent advance
暂未订购
导出
摘要 原发性醛固酮增多症患者中,高血压、胰岛素抵抗等代谢紊乱,以及心血管事件的发生率较原发性高血压患者明显升高,在诊断、治疗原发性醛固酮增多症的同时,关注其可能会引起的代谢紊乱及心血管事件,对改善患者预后有一定的帮助。 Metabolic disturbances such as hypertension and insulin resistenee, as well as cardiovascular events are more frequent in primary aldosteronism patients than in essential hypertension patients. When the diagnosis of primary aldosteronism is made, more attention should be paid to the associated metabolic disturbances and cardiovascular events,which may benefit the prognosis of patients.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2010年第1期71-72,共2页 Chinese Journal of Practical Internal Medicine
关键词 原发性醛固酮增多症 代谢紊乱 心血管事件 primary aldosteronism metabolic disturbance cardiovascular risk
  • 相关文献

参考文献14

  • 1Kidambi S. Kotchen JM, Grim CE, et al. Association of adrenal steroids with hypertension and the metabolic syndrome in blacks [J]. Hypertension, 2007,49 ( 3 ) :704 - 711.
  • 2Fallo F, Veglio F, Bertello C, et al. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism[J]. J Clin Endocrinol Metab, 2006,91 ( 2 ) :454 - 459.
  • 3周亚茹,曾正陪,张晶,童安莉,卢琳,宋爱羚,夏维波,付勇,姜艳,陈适,梁伟,茅江峰,张化冰,李伟.原发性醛固酮增多症的胰岛素抵抗及葡萄糖代谢异常[J].中华内分泌代谢杂志,2006,22(3):294-297. 被引量:26
  • 4Bochud M, Nussberger J, Bovet P, et al. Plasma aldosterone is independently associated with the metabolic syndrome [ J]. Hypertension,2006,48 ( 2 ) :239 - 245.
  • 5Gaudio G, Guasti L, Schizzarotto A, et al. Changes in plasma lipids during renin-angiotensin system blockade by combination therapy (enalapril plus valsartan) in patients with diabetes and hypertension [J].J Cardiovasc Pharmacol, 2005,45 ( 4 ) : 362 - 366.
  • 6Vasan RS, Evans JC, Larson MG, et al. Serum aldosterone and the incidence of hypertension ill nonhypertensive persons [ J ]. N Engl J Med,2004,351 (1) :33 -41.
  • 7Rossi G,Boscaro M ,Ronconi V ,et al. Aldosterone as a cardiovascular risk factor [ J ], Trends Endocrinol Metab, 2005,16 ( 3 ) : 104 - 107.
  • 8Milliez P, Girerd X, Plouin PF, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism [J]. J Am Coil Cardiol,2005,45 (8) :1243 -1248.
  • 9Colussi G, Catena C, Lapenna R, et aL Insulin resistance and hy- perinsulinemia are related to plasma aldosterone levels in hypertensive patients [ J ]. Diabetes Care,2007,30 (9) :2349 - 2354.
  • 10Luther JM,Gainer JV, Murphey LJ,et al. Angiotensin Ⅱ induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism [ J ]. Hypertension, 2006,48 ( 6 ) : 1050 - 1057.

二级参考文献13

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3086
  • 2杨文英,杨兆军,李光伟,邢小燕.联合测量腰臀围比值(或腰围)和血压可预测代谢综合征[J].中华内分泌代谢杂志,2005,21(3):227-229. 被引量:92
  • 3杨文英.空腹血糖受损下限诊断切割点的建议[J].中华医学杂志,2005,85(28):1947-1950. 被引量:86
  • 4Conn JW. The potassium and impaired glucose tolerance, N Engl J Med, 1965,273 : 1135-1143,
  • 5Widimsky Jr,Sindelka G, Haas T, et al. Impaired insulin action in primary hyperaldosteronism. Physiol Res, 2000,49:241-244.
  • 6曾正陪.肾上腺疾病.史轶蘩,主编.协和内分泌代谢学.北京:科学出版社,1999,1190—1191.
  • 7Sindelka G, Widimsky J, Haas T, et al, Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment. Exp Clin Endocrinol Diabetes, 2000,108:21-25.
  • 8Campion J, Maestro B, Mata F, et al. Inhibition by aldosterone of insulin receptor mRNA levels and insulin binding in U-937 human promonocytic cells. J Steroid Biochem Mol Biol, 1999,70:211-218.
  • 9Kraus D, Jager J, Meier B, et al. Aldosterone inhibits uncoupling protein-1, induces insulin resistance, and stimulates proinflammatory adipokines in adipocytes. Horm Metab Res, 2005,37:455-459.
  • 10Sartipy P, Loskutoff D J, Monocyte chemoattractant protein 1 in obesity and insulin resistance, Proc Natl Acad Sci U S A, 2003,100:7265-770.

共引文献25

同被引文献10

  • 1Morillas P, Castillo J, Quiles J, et al. Prevalence of primary aldosteronism in hypertensive patients and its effect on the heart [J]. Rev Esp Cardiol,2008,61 (4): 418.
  • 2Sechi LA, Colussi G, Di Fabio A, et al. Cardiovascular and renal damage in primary aldostercnism: outcomes after treatment [J]. Am J Hypertens,2010,23(12): 1253.
  • 3Jakubik P,Janota T,Widimsky J Jr,et al. Impact of essen- tial hypertension and primary aldosteronism on plasma brain natri- uretic peptide concentration [ J ]. Blood Press,2006,15 (5) : 302.
  • 4Muiesan ML, Salvetti M, Paini A, et al. Inappropriate left ventrieular mass in patients with primary aldosteronism [ J]. Hy- pertension, 2008,52 ( 3 ) : 529.
  • 5Galetta F, Bernini G, Franzoni F, et al. Cardiac remodeling in patients with primary aldosteronism [ J ]. J Endocrinol Invest, 2009,32(9) : 739.
  • 6Tsioufis C,Tsiachris D,Dimitriadis K,et al. Myocardial and aortic stiffening in the early course of primary aldosteronism [ J]. Clin Cardiol,2008,31 (9) : 431.
  • 7Catena C,Colussi G,Nadalini E,et al.Cardiovascular outcomes in patients withprimary aldosteronism after treatment[].Archives of Internal Medicine.2008
  • 8洪维,龚艳春,初少莉,陈绍行,郭冀珍,朱鼎良.原发性醛固酮增多症患者与左心室肥厚[J].中华高血压杂志,2008,16(2):112-116. 被引量:11
  • 9赵铁耘,李芳,李秀钧.原发性醛固酮增多症药物治疗进展[J].中国实用内科杂志,2010,30(1):17-19. 被引量:5
  • 10曾正陪.原发性醛固酮增多症临床实践指南解读[J].中国实用内科杂志,2010,30(1):29-31. 被引量:21

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部